Grail

grail.com

GRAIL is a healthcare company focused on early cancer detection through its innovative Galleri test, a multi-cancer early detection (MCED) blood test that analyzes DNA shed into the bloodstream. The company leverages advanced methylation technology and machine-learning algorithms to identify cancer signals, aiming to transform cancer screening and improve patient outcomes. Founded in 2016, GRAIL collaborates with leading healthcare systems and biopharma partners to enhance its offerings and expand its market presence, positioning itself as a leader in precision oncology.